An Update On Ascendis Pharma’s Path To Profitability

Summit Therapeutics’ Ivonescimab: Strong Buy Its Dual-Action Approach To Cancer

Ratio Therapeutics Appoints Marc Becker as Chief Financial Officer and Chief Operating Officer

2024’s Best & Worst States for Nurses – WalletHub Study

2024’s Best & Worst States for Children’s Health Care – WalletHub Study

Rebound Medical Receives Growth Equity Investment from Castleford Capital

Flagship Appoints Amy O’Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences

Usha Chakravarthy, Allen Ho and Frank Holz Join EyePoint Pharmaceuticals’ Scientific Advisory Board

Healthiest Cities in America (2024 Rankings) – WalletHub Study

Praxis Precision Medicines Prices of $200 Million Public Offering

Sirtex Medical Appoints Matt Schmidt as Chief Executive Officer

Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues

Fusion Pharmaceuticals to be Acquired by AstraZeneca

Syndax Appoints Steven Closter as Chief Commercial Officer

2024’s Best & Worst States for Doctors – WalletHub Study

Pfizer: It’s Darkest Before The Dawn, Upgrading To ‘Strong Buy’